The BULLSEYE study suggests a role for [177Lu]Lu-PSMA-617 in the management of oligometastatic hormone-sensitive prostate cancer.
European urology focus. 2026 Aug 05 [Epub ahead of print]
Bastiaan M Privé, Daniela E Oprea-Lager, Constantijn H J Muselaers, Bart Timmermans, Inge M van Oort, Niven Mehra, J P Michiel Sedelaar, Alexis Vrachimis, Walter Noordzij, James Nagarajah
Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands. Electronic address: ., Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Department of Urology, Radboudumc, Nijmegen, The Netherlands., Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands., Department of Urology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands., Department of Urology, Radboudumc, Nijmegen, The Netherlands; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands., Department of Nuclear Medicine, German Medical Institute, European University Cyprus, Limassol, Cyprus., Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands; Roentgeninstitut Duesseldorf, Duesseldorf, Germany.